Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: August 16, 2018

DrugPatentWatch Database Preview

Osmotica Pharm Us Company Profile

« Back to Dashboard

What is the competitive landscape for OSMOTICA PHARM US, and what generic and branded alternatives to OSMOTICA PHARM US drugs are available?

OSMOTICA PHARM US has four approved drugs.

Summary for Osmotica Pharm Us

US Patents:	0
Tradenames:	3
Ingredients:	3
NDAs:	4

Drugs and US Patents for Osmotica Pharm Us

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Osmotica Pharm Us	NIFEDIPINE	nifedipine	TABLET, EXTENDED RELEASE;ORAL	077127-002	Nov 21, 2005	AB2	RX	No	No		➤ Sign Up				➤ Sign Up
Osmotica Pharm Us	OXYBUTYNIN CHLORIDE	oxybutynin chloride	TABLET, EXTENDED RELEASE;ORAL	078503-002	Feb 4, 2009	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Osmotica Pharm Us	OXYBUTYNIN CHLORIDE	oxybutynin chloride	TABLET, EXTENDED RELEASE;ORAL	078503-001	Feb 4, 2009	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Osmotica Pharm Us	DONEPEZIL HYDROCHLORIDE	donepezil hydrochloride	TABLET;ORAL	203114-001	Jan 26, 2016	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Osmotica Pharm Us	NIFEDIPINE	nifedipine	TABLET, EXTENDED RELEASE;ORAL	077410-001	Oct 3, 2007	AB2	RX	No	No		➤ Sign Up				➤ Sign Up
Osmotica Pharm Us	OXYBUTYNIN CHLORIDE	oxybutynin chloride	TABLET, EXTENDED RELEASE;ORAL	078503-003	Feb 4, 2009	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter

Cerilliant

Cantor Fitzgerald

Boehringer Ingelheim

Teva

Julphar

Chinese Patent Office

Colorcon

UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.